Showing results (31-40 of 617) with videos related to
Sort By:
Pageof 62
The Oncologist|February 1, 2021
Safety of Direct Oral Anticoagulants in Central Nervous System MalignanciesAndrew W Swartz, Jan DrappatzLeukemia & Lymphoma|June 5, 2012
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphomaLakshmi Nayak, Lauren E Abrey, Jan Drappatz, et al.Journal of Neuro-Oncology|December 2, 2008
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant gliomaAndrew D Norden, Jan Drappatz, Alona Muzikansky, et al.Journal of Neuro-Oncology|July 6, 2013
Retrospective study of pemetrexed as salvage therapy for central nervous system lymphomaJun-Ping Zhang, Eudocia Q Lee, Lakshmi Nayak, et al.Journal of Neuro-Oncology|May 21, 2018
Retrospective study of nivolumab for patients with recurrent high grade gliomasMegan Mantica, Ashley Pritchard, Frank Lieberman, et al.Journal of Neuro-Oncology|June 28, 2011
Safety of concurrent bevacizumab therapy and anticoagulation in glioma patientsAndrew D Norden, Julia Bartolomeo, Shota Tanaka, et al.Archives of Neurology|March 10, 2010
Morphological characteristics of brain tumors causing seizuresJong Woo Lee, Patrick Y Wen, Shelley Hurwitz, et al.Journal of Neuro-Oncology|September 8, 2010
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomideElizabeth R Gerstner, April F Eichler, Scott R Plotkin, et al.Expert Review of Anticancer Therapy|September 15, 2010
American Society of Clinical Oncology 2010: report of selected studies from the CNS tumors sectionPatrick Y WenPageof 62